Aspen secures Indian Serum Institute deal

JOHANNESBURG - SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has secured a 10-year agreement with the Serum Institute of India.

It will bottle four vaccines before marketing and distributing them under its own brand in Africa.

WATCH: Aspen concludes vaccine deal with J&J 

It's good news for Aspen’s Gqeberha facility, where production lines were left idle because of lower-than-expected sales of Johnson & Johnson’s Covid-19 vaccines.

Aspen’s CEO Stephen Saad says the production of Covid shots demonstrates Africa's capacity to manufacture vaccines.